Publications
- Durvalumab in the treatment of locally advanced unresectable non‑small cell lung cancer – case report2023 | First Faculty of Medicine, Third Faculty of Medicine
- Treatment with pembrolizumab in a patient with non-small cell lung cancer after a faecal transplantation - case report2023 | First Faculty of Medicine, Third Faculty of Medicine
- Immunotherapy in patients with small cell lung cancer, a chance for a longer and quality life - case report2023 | Third Faculty of Medicine
- Major changes in the treatment of small cell lung cancer2023 | Third Faculty of Medicine
- Two years longer and peaceful life thanks to alectinib2022 | Third Faculty of Medicine, Central Library of Charles University
- Lorlatinib in a pretreated patient with ALK-positive lung adenocarcinoma2021 | Third Faculty of Medicine
- Atezolizumab ve studii OAK naděje pro nemocné s pokročilým nemalobuněčným karcinomem plic2020 | Third Faculty of Medicine
- Role of alectinib in the treatment of advanced non-small cell lung cancer2020 | Third Faculty of Medicine
- Longer survival in patients with NSCLC thanks to the combination of chemotherapy, immunotherapy and targeted therapy in the first line palliative treatment - results of the IMpower150 study2020 | Third Faculty of Medicine
- Alektinib v první linii léčby u nemocné s adenokarcinomem plic2020 | Third Faculty of Medicine
Loading network view...